About GT Metabolic Solutions
GT Metabolic Solutions is a company based in Saint Michael (United States) founded in 2020 by Thierry Thaure and Michel Gagner. It operates as a Direct-to-Consumer (D2C). GT Metabolic Solutions has raised $17.08 million across 1 funding round. GT Metabolic Solutions offers products and services including MagDI™ System. GT Metabolic Solutions operates in a competitive market with competitors including Allurion, Apollo Endo, Sedivention, IG Balloon and Spatz FGIA, among others.
- Headquarter Saint Michael, United States
- Founders Thierry Thaure, Michel Gagner
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gt Metabolic Solutions, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.08 M (USD)
in 1 rounds
-
Latest Funding Round
$17.08 M (USD), Series B
Nov 06, 2023
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GT Metabolic Solutions
GT Metabolic Solutions offers a comprehensive portfolio of products and services, including MagDI™ System.
Used for magnetic duodeno-ileal anastomosis in surgery.
People of GT Metabolic Solutions
Unlock access to complete
Funding Insights of GT Metabolic Solutions
GT Metabolic Solutions has successfully raised a total of $17.08M through 1 strategic funding round. The most recent funding activity was a Series B round of $17.08 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by GT Metabolic Solutions
Investment portfolio details for GT Metabolic Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GT Metabolic Solutions
Detailed financials for GT Metabolic Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gt Metabolic Solutions Comparisons
Peer comparison for GT Metabolic Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GT Metabolic Solutions
GT Metabolic Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Allurion, Apollo Endo, Sedivention, IG Balloon and Spatz FGIA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Satiety induction through digestable gastric balloon introduced via a swallowed capsule
|
|
| Locked | Locked | Locked |
Therapeutic devices for obesity and GI disorders are developed.
|
|
| Locked | Locked | Locked |
Developer of a minimally invasive cryo-ablation therapy for obesity. This outpatient procedure uses cryo-ablation technology to disrupt the gastric branches of the vagus nerve, permanently reducing hunger feelings. A medical device has been developed and successfully tested for safety and efficacy. The therapy aims to provide a long-term solution for weight loss, addressing a significant unmet medical need. The company is supported by several awards and investments.
|
|
| Locked | Locked | Locked |
Offers updates on medical device designs and clinical trial outcomes.
|
|
| Locked | Locked | Locked |
Minimally invasive gastric balloon is developed for obesity satiety induction.
|
Detailed competitors of GT Metabolic Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gt Metabolic Solutions
Complete news archive for GT Metabolic Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GT Metabolic Solutions
GT Metabolic Solutions was founded in 2020 and raised its 1st funding round 3 years after it was founded.
GT Metabolic Solutions is headquartered in Saint Michael, United States. It is registered at Saint Michael, Minnesota, United States.
Thierry Thaure is the current CEO of GT Metabolic Solutions. They have also founded this company.
GT Metabolic Solutions is a funded company, having raised a total of $17.08M across 1 funding round to date.
GT Metabolic Solutions is engaged in developing magnetic compression anastomosis technologies for minimally invasive surgical procedures. The company targets bariatric, metabolic, and digestive surgeries with innovative solutions like the MagDI System. This system is used to create incisionless, sutureless, and staple-free anastomoses, primarily for weight loss and type 2 diabetes management in obese patients. Partnerships with leading surgeons worldwide are maintained to deliver safer surgical products and techniques across the healthcare sector.
GT Metabolic Solutions's top competitors include Allurion, Apollo Endo and Sedivention.
GT Metabolic Solutions offers MagDI™ System.